Baker Brothers Life Sciences LP, Director, 10% Owner at GENOMIC HEALTH INC (GHDX), sold 203,952 shares at $79.07 ($16.2M) on 2018-11-30, disclosed to the SEC on 2018-12-03.
Open-market sale of $16.2M GHDX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.07 | 129,121 | $10.2M | 63.2% |
| 2 | $79.07 | 1,981 | $157K | 1.0% |
| 3 | $79.07 | 2,214 | $175K | 1.1% |
| 4 | $79.07 | 3,417 | $270K | 1.7% |
| 5 | $79.07 | 19,824 | $1.6M | 9.7% |
| 6 | $79.63 | 1,048 |
| $83K |
| 0.5% |
| 7 | $79.63 | 6,078 | $484K | 3.0% |
| 8 | $79.63 | 678 | $54K | 0.3% |
| 9 | $79.63 | 39,591 | $3.2M | 19.5% |
| Total | $79.20 avg | 203,952 | $16.2M | 100% |
| Filing → |
| IGMS | BUY | 2023-12-15 | $5.4M | — | Filing → |
| MDGL | BUY | 2023-11-21 | $22.1M | — | Filing → |
| BGNE | SELL | 2023-11-14 | $198.6M | — | Filing → |